FdaApplication
NDA 211710
Identifiers
- fda_app_no: NDA211710
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-11-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VITRAKVI | LAROTRECTINIB SULFATE | EQ 20MG BASE/ML | SOLUTION;ORAL |
1 product